|
Volumn 16, Issue 3, 2009, Pages 478-480
|
Initial clinical experience with a selective A2A receptor agonist, regadenoson, in a patient with end-stage renal disease on hemodialysis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOPHYLLINE;
REGADENOSON;
ADENOSINE A2A RECEPTOR;
DIAGNOSTIC AGENT;
PURINE DERIVATIVE;
PYRAZOLE DERIVATIVE;
ADULT;
ANGIOCARDIOGRAPHY;
ARTICLE;
BLOOD PRESSURE;
CASE REPORT;
CORONARY ARTERY CIRCUMFLEX BRANCH;
ELECTROCARDIOGRAM;
FEMALE;
HEART MUSCLE ISCHEMIA;
HEART MUSCLE PERFUSION;
HEMODIALYSIS;
HUMAN;
IN-STENT RESTENOSIS;
KIDNEY FAILURE;
NAUSEA;
PREOPERATIVE CARE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SIDE EFFECT;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
ST SEGMENT DEPRESSION;
THORAX PAIN;
CHRONIC KIDNEY FAILURE;
DRUG ANTAGONISM;
PILOT STUDY;
RADIOGRAPHY;
SCINTISCANNING;
ADULT;
FEMALE;
HUMANS;
KIDNEY FAILURE, CHRONIC;
MYOCARDIAL ISCHEMIA;
PILOT PROJECTS;
PURINES;
PYRAZOLES;
RECEPTOR, ADENOSINE A2A;
|
EID: 68049139459
PISSN: 10713581
EISSN: None
Source Type: Journal
DOI: 10.1007/s12350-008-9043-z Document Type: Article |
Times cited : (9)
|
References (5)
|